We use cookies for a better user experience. Read our Privacy Policy

I Agree

Plant-based Vaccines Market Trends, 2021-2031

Plant-based Vaccines Market (Type: Bacterial Vaccine, Viral Vaccine, and Others; Plant Source: Tobacco, Potato, and Others; and Application: Against Infectious Agents, Anti-Cancer, and Against Autoimmune Disorders) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Plant-based Vaccines Hold Strong Prospects for Developing COVID-19 Antibodies

Researchers are undertaking significant R&D efforts to identify the viability of plant-based vaccines to combat the spread of COVID-19. Companies in the plant-based vaccines market are under great scrutiny for using plants in the production of vaccines, monoclonal antibodies, and immunomodulatory proteins to reduce morbidity and mortality associated with the novel coronavirus. Plant-based vaccines are considered generally stable, safe, and effective against potential infections.

Plant molecular farming hold promising potentials for the rapid production of biologics on an industrial scale. Companies in the plant-based vaccines market are capitalizing on this opportunity during the pandemic to increase research expenditure in plant biopharming in addition to its prospective applications for developing effective vaccines and antibodies to counter COVID-19.

plant based vaccines market infographic

To know the scope of our report Get a Sample on Plant-based Vaccines Market

Obstacles in Development of 3rd Generation Vaccines Affecting Market Growth

The plant-based vaccines market is projected to expand at a favorable CAGR of 7.38% during the assessment period. However, manufacturers are facing obstacles in the development of 3rd generation vaccines. Hence, companies are taking progressive steps to produce effective vaccines against human and animal-associated diseases by increasing their research expenditure. As such, high cost production and time-consuming production of traditional vaccines are translating into revenue opportunities for companies in the plant-based vaccines market.

The plant-based vaccine technology is based on the insertion of the encoded protein with the desired gene for the specific disease into the plant genome by several methods. The most popular method for the production of vaccines by plant is Agrobacterium mediated gene transformation, which is genetically modified with plant viruses and used to generate plant vaccines.

Get a glimpse of the in-depth analysis through our Report Brochure

Low Up-front Investment, Time Efficiency Helpful in Plant-based Vaccine Production

Plant-based production saves months in initial setup time compared with competing recombinant protein methods. iBio’s FastPharming® system is gaining recognition for using plants as bioreactors, which eliminates the need for expensive and labor-intensive cell line development with respect to traditional vaccines. Such factors are contributing to the growth of the plant-based vaccines market.

The required up-front investment for plant-based vaccine production is less expensive as compared to mammalian cell culture systems. Tight control of posttranslational modifications (PTMs) is being made possible with robust plant-based expression technologies, owing to increased molecule quality and potency.

Companies Consider Technicalities for Production of Recombinant Vaccine Antigens in Plant Systems

The plant-based vaccine production for humans and animals has been under serious consideration to overcome issues associated with biosafety, cost, and distribution. Plant biotechnology is bringing new insights to vaccines research through gene transfer strategies to plants and improvements in amount, isolation, and purification for the production of recombinant vaccine against antigens in plants.

Significant increase in world population and emergence of epidemic & pandemic diseases are key drivers of the plant-based vaccines market. Since plant produce complex proteins similar to other eukaryotic systems, researchers are modifying these proteins with the help of clinical trials. Companies in the plant-based vaccines market are taking into consideration the plant transformation and the production of recombinant protein in plants for the production of recombinant vaccine antigens in plant systems.

plant based vaccines market segmentation

Expanding operations in future? To get the perfect launch ask for a custom report

Analysts’ Viewpoint

Novel diseases, such as COVID-19, Ebola, and Zika, among others, are fueling the requirement of dynamic vaccine research and investment using plant systems. The plant-based vaccines market is undergoing a significant change with plant-based expression technologies that help to reduce cost and time associated with traditional vaccines. However, manufacturers are facing challenges in the development of 3rd generation vaccines. Hence, companies should use enhanced technologies that include electroporation, sonication, and biolistic methods to develop 3rd generation plant vaccines. These methods are helping in the production of edible vaccines that suit the convenience of individuals and effective against human and animal-associated diseases.

Plant-based Vaccines Market: Overview

  • According to Transparency Market Research’s latest research report on the global plant-based vaccines market for the historical period of 20172019 and the forecast period of 20212031, increase in incidence of infections, government initiatives for expansion of vaccination coverage, and government funding for vaccine development are projected to drive the global plant-based vaccines market in the near future
  • According to the report, the global plant-based vaccines market was valued at US$ 1.10 Bn in 2020, and it is anticipated to expand at a CAGR of 7.38% from 2021 to 2031

Increase in Incidence of Infections: Key Driver

  • Emerging and re-emerging infectious diseases are deemed to be a public health threat worldwide. A need for constant awareness and readiness, and preparedness to deal with infectious disease outbreaks, which may cause a dangerous threat to the public, has been observed.
  • According to the BioMed Central Ltd (part of Springer Nature), the Centers for Diseases Control and Prevention defined syndromic surveillance (SS) as surveillance using health-related data that precedes diagnosis and signals a sufficient probability of a case or an outbreak to warrant further public health response
  • Furthermore, high prevalence of infectious diseases, such as hepatitis, tuberculosis, retroviral infections, and endocrine disorders, viz., diabetes, thyroid disorders, etc., is likely to drive the demand for rapid diagnostics test readers during the forecast period
  • According to the World Health Organization, in 2016, more than 71 million people were affected with hepatitis C infection globally. Moreover, according to the HIV.gov website, around 36.7 million people were living with HIV/AIDS worldwide by the end of 2016.
  • Thus, high prevalence and rise in incidence rate of infectious diseases across the globe is a key driver of the market

Increase in Incidence Rate of Influenza: Major Driver

  • Influenza is a respiratory infection caused by influenza viruses and spreads easily. Influenza viruses undergo constant genetic change, which has substantial impact on induced immunity and considerations for vaccine composition.
  • According to the World Health Organization (WHO), when an infected person coughs or sneezes, droplets containing viruses (infectious droplets) are dispersed into the air and can spread up to one meter, and infect persons in close proximity who breathe these droplets in
  • People should cover their mouth and nose with a tissue while coughing and wash their hands regularly in order to prevent transmission
  • Hence, increase in incidence rate of influenza drives the global plant-based vaccines market

Plant-based Vaccines Market: Competition Landscape

  • This report profiles major players operating in the global plant-based vaccines market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global plant-based vaccines market is moderately fragmented, with the presence of a large number of leading players in the global market and several small players in regional markets. The top players hold a major share of the global plant-based vaccines market.
  • Prominent players operating in the global plant-based vaccines market include
    • Creative Biolabs
    • Medicago Inc.
    • iBio
    • Fraunhofer Center for Manufacturing Innovation
    • ICON
    • EEA Consulting Engineers
    • Protalix
    • Kentucky BioProcessing, Inc.
  • The report on the global plant-based vaccines market discusses individual strategies, followed by company profiles of providers of plant-based vaccines. The competition landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global plant-based vaccines market.

Plant-based Vaccines Market – Segmentation

Type
  • Bacterial Vaccine
  • Viral Vaccine
  • Others
Plant Source
  • Tobacco
  • Potato
  • Others
Application
  • Against Infectious Agents
  • Anti-Cancer
  • Against Autoimmune Disorders
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Plant-based Vaccines Market Trends, 2021-2031

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of plant-based vaccines market?

The global plant-based vaccines market was worth US$ 1.10 Bn and is projected to reach a value of US$ 2.34 Bn by the end of 2031

What is the anticipated CAGR of the plant-based vaccines market in the forecast period?

Plant-based vaccines market is anticipated to grow at a CAGR of 7.38% during the forecast period

Which region is expected to project the highest share in global plant-based vaccines market?

North America accounted for a major share of the global plant-based vaccines market

What are the key driving factors for the growth of the plant-based vaccines market?

Plant-based vaccines market is driven by increase in incidence of infections, government initiatives for expansion of vaccination coverage, and government funding for vaccine development are projected to drive the global market

Who are the key players in the global plant-based vaccines market?

Key players in the global plant-based vaccines market include Creative Biolabs, Medicago Inc., iBio, Fraunhofer Center for Manufacturing Innovation, ICON, EEA Consulting Engineers, Protalix, and Kentucky BioProcessing, Inc.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Plant-based Vaccines Market

4. Market Overview

    4.1. Introduction

        4.1.1. Type Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Plant-based Vaccines Market Analysis and Forecast, 2017–2031

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Pipeline Analysis

    5.2. Key Industry Events (Mergers, Acquisitions, Partnerships, Collaborations, etc.)

    5.3. COVID-19 Pandemics Impact on Industry (Value Chain and Short / Mid / Long Term Impact)

    5.4. Overview of Plant-based Vaccines

6. Global Plant-based Vaccines Market Analysis and Forecast, by Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Global Plant-based Vaccines Market Value (US$ Mn) Forecast, by Type, 2017–2031

        6.3.1. Bacterial Vaccine

        6.3.2. Viral Vaccine

        6.3.3. Others

    6.4. Global Plant-based Vaccines Market Attractiveness, by Type

7. Global Plant-based Vaccines Market Analysis and Forecast, by Plant source

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Global Plant-based Vaccines Market Value (US$ Mn) Forecast, by Plant source, 2017–2031

        7.3.1. Tobacco

        7.3.2. Potato

        7.3.3. Others

    7.4. Global Plant-based Vaccines Market Attractiveness, by Plant source

8. Global Plant-based Vaccines Market Analysis and Forecast, by Application

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Global Plant-based Vaccines Market Value (US$ Mn) Forecast, by Application, 2017–2031

        8.3.1. Against Infectious Agents

        8.3.2. Anti-Cancer

        8.3.3. Against Autoimmune Disorders

    8.4. Global Plant-based Vaccines Market Attractiveness, by Application

9. Global Plant-based Vaccines Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Global Plant-based Vaccines Market Value (US$ Mn) Forecast, by Region

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Global Plant-based Vaccines Market Attractiveness, by Country/Region

10. North America Plant-based Vaccines Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. North America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Type, 2017–2031

        10.2.1. Bacterial Vaccine

        10.2.2. Viral Vaccine

        10.2.3. Others

    10.3. North America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Plant source, 2017–2031

        10.3.1. Tobacco

        10.3.2. Potato

        10.3.3. Others

    10.4. North America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Application, 2017–2031

        10.4.1. Against Infectious Agents

        10.4.2. Anti-Cancer

        10.4.3. Against Autoimmune Disorders

    10.5. North America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Country, 2017–2031

        10.5.1. U.S.

        10.5.2. Canada

    10.6. North America Plant-based Vaccines Market Attractiveness Analysis

        10.6.1. By Type

        10.6.2. By Plant source

        10.6.3. By Application

        10.6.4. By Country

11. Europe Plant-based Vaccines Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Europe Plant-based Vaccines Market Value (US$ Mn) Market Value  Forecast, by Type, 2017–2031

        11.2.1. Bacterial Vaccine

        11.2.2. Viral Vaccine

        11.2.3. Others

    11.3. Europe Plant-based Vaccines Market Value (US$ Mn) Forecast, by Plant source, 2017–2031

        11.3.1. Tobacco

        11.3.2. Potato

        11.3.3. Others

    11.4. Europe Plant-based Vaccines Market Value (US$ Mn) Forecast, by Application, 2017–2031

        11.4.1. Against Infectious Agents

        11.4.2. Anti-Cancer

        11.4.3. Against Autoimmune Disorders

    11.5. Europe Plant-based Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Europe Plant-based Vaccines Market Attractiveness Analysis

        11.6.1. By Type

        11.6.2. By Plant source

        11.6.3. By Application

        11.6.4. By Country/Sub-region

12. Asia Pacific Plant-based Vaccines Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Asia Pacific Plant-based Vaccines Market Value (US$ Mn) Forecast, by Type, 2017–2031

        12.2.1. Bacterial Vaccine

        12.2.2. Viral Vaccine

        12.2.3. Others

    12.3. Asia Pacific Plant-based Vaccines Market Value (US$ Mn) Forecast, by Plant source, 2017–2031

        12.3.1. Tobacco

        12.3.2. Potato

        12.3.3. Others

    12.4. Asia Pacific Plant-based Vaccines Market Value (US$ Mn) Forecast, by Application, 2017–2031

        12.4.1. Against Infectious Agents

        12.4.2. Anti-Cancer

        12.4.3. Against Autoimmune Disorders

    12.5. Asia Pacific Plant-based Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Asia Pacific Plant-based Vaccines Market Attractiveness Analysis

        12.6.1. By Type

        12.6.2. By Plant source

        12.6.3. By Application

        12.6.4. By Country/Sub-region

13. Latin America Plant-based Vaccines Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Latin America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Type, 2017–2031

        13.2.1. Bacterial Vaccine

        13.2.2. Viral Vaccine

        13.2.3. Others

    13.3. Latin America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Plant source, 2017–2031

        13.3.1. Tobacco

        13.3.2. Potato

        13.3.3. Others

    13.4. Latin America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Application, 2017–2031

        13.4.1. Against Infectious Agents

        13.4.2. Anti-Cancer

        13.4.3. Against Autoimmune Disorders

    13.5. Latin America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Latin America Plant-based Vaccines Market Attractiveness Analysis

        13.6.1. By Type

        13.6.2. By Plant source

        13.6.3. By Application

        13.6.4. By Country/Sub-region

14. Middle East & Africa Plant-based Vaccines Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Middle East & Africa Plant-based Vaccines Market Value (US$ Mn) Forecast, by Type, 2017–2031

        14.2.1. Bacterial Vaccine

        14.2.2. Viral Vaccine

        14.2.3. Others

    14.3. Middle East & Africa Plant-based Vaccines Market Value (US$ Mn) Forecast, by Plant source, 2017–2031

        14.3.1. Tobacco

        14.3.2. Potato

        14.3.3. Others

    14.4. Middle East & Africa Plant-based Vaccines Market Value (US$ Mn) Forecast, by Application, 2017–2031

        14.4.1. Against Infectious Agents

        14.4.2. Anti-Cancer

        14.4.3. Against Autoimmune Disorders

    14.5. Middle East & Africa Plant-based Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Middle East & Africa Plant-based Vaccines Market Attractiveness Analysis

        14.6.1. By Type

        14.6.2. By Plant source

        14.6.3. By Application

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player – Competition Matrix (By Tier and Size of companies)

    15.2. Market Share Analysis By Company (2020)

    15.3. Company Profiles

        15.3.1. Creative Biolabs

            15.3.1.1. Company Overview

            15.3.1.2. Company Financials

            15.3.1.3. Growth Strategies

            15.3.1.4. SWOT Analysis

        15.3.2. Medicago Inc.

            15.3.2.1. Company Overview

            15.3.2.2. Company Financials

            15.3.2.3. Growth Strategies

            15.3.2.4. SWOT Analysis

        15.3.3. iBio

            15.3.3.1. Company Overview

            15.3.3.2. Company Financials

            15.3.3.3. Growth Strategies

            15.3.3.4. SWOT Analysis

        15.3.4. Fraunhofer Center for Manufacturing Innovation

            15.3.4.1. Company Overview

            15.3.4.2. Company Financials

            15.3.4.3. Growth Strategies

            15.3.4.4. SWOT Analysis

        15.3.5. ICON

            15.3.5.1. Company Overview

            15.3.5.2. Company Financials

            15.3.5.3. Growth Strategies

            15.3.5.4. SWOT Analysis

        15.3.6. EEA Consulting Engineers

            15.3.6.1. Company Overview

            15.3.6.2. Company Financials

            15.3.6.3. Growth Strategies

            15.3.6.4. SWOT Analysis

        15.3.7. Protalix

            15.3.7.1. Company Overview

            15.3.7.2. Company Financials

            15.3.7.3. Growth Strategies

            15.3.7.4. SWOT Analysis

        15.3.8. Kentucky BioProcessing, Inc.

            15.3.8.1. Company Overview

            15.3.8.2. Company Financials

            15.3.8.3. Growth Strategies

            15.3.8.4. SWOT Analysis

        15.3.9. Other Prominent Key Players

List of Tables

Table 01: Global Plant-based Vaccines Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 02: Global Plant-based Vaccines Market Value (US$ Mn) Forecast, by Plant Source, 2017–2031

Table 03: Global Plant-based Vaccines Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 04: Global Plant-based Vaccines Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 05: North America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 06: North America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 07: North America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Plant Source, 2017–2031

Table 08: North America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 09: Europe Plant-based Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 10: Europe Plant-based Vaccines Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 11: Europe Plant-based Vaccines Market Value (US$ Mn) Forecast, by Plant Source, 2017–2031

Table 12: Europe Plant-based Vaccines Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 13: Asia Pacific Plant-based Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Asia Pacific Plant-based Vaccines Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 15: Asia Pacific Plant-based Vaccines Market Value (US$ Mn) Forecast, by Plant Source, 2017–2031

Table 16: Asia Pacific Plant-based Vaccines Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 17: Latin America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 18: Latin America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 19: Latin America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Plant Source, 2017–2031

Table 20: Latin America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 21: Middle East & Africa Plant-based Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 22: Middle East & Africa Plant-based Vaccines Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 23: Middle East & Africa Plant-based Vaccines Market Value (US$ Mn) Forecast, by Plant Source, 2017–2031

Table 24: Middle East & Africa Plant-based Vaccines Market Value (US$ Mn) Forecast, by Application, 2017–2031

List of Figures

Figure 1: Global Plant-based Vaccines Market Value (US$ Mn) Forecast, 2017–2031

Figure 2: Global Plant-based Vaccines Market Value Share, by Type (2020)

Figure 3: Global Plant-based Vaccines Market Value Share, by Plant source (2020)

Figure 4: Global Plant-based Vaccines Market Value Share, by Application (2020)

Figure 5: Global Plant-based Vaccines Market Value Share, by Region (2020)

Figure 6: Global Plant-based Vaccines Market Value Share Analysis, by Type, 2021 and 2031

Figure 7: Global Plant-based Vaccines Market Attractiveness Analysis, by Type, 2021–2031

Figure 8: Global Plant-based Vaccines Market Value (US$ Mn), by Bacterial Vaccine, 2017–2031

Figure 9: Global Plant-based Vaccines Market Value (US$ Mn), by Viral Vaccine, 2017–2031

Figure 10: Global Plant-based Vaccines Market Value (US$ Mn), by Others, 2017–2031

Figure 11: Global Plant-based Vaccines Market Value Share Analysis, by Plant source, 2021 and 2031

Figure 12: Global Plant-based Vaccines Market Attractiveness Analysis, by Plant source, 2021–2031

Figure 13: Global Plant-based Vaccines Market Value (US$ Mn), by Tobacco, 2017–2031

Figure 14: Global Plant-based Vaccines Market Value (US$ Mn), by Potato, 2017–2031

Figure 15: Global Plant-based Vaccines Market Value (US$ Mn), by Others, 2017–2031

Figure 16: Global Plant-based Vaccines Market Value Share Analysis, by Application, 2021 and 2031

Figure 17: Global Plant-based Vaccines Market Attractiveness Analysis, by Application, 2021–2031

Figure 18: Global Plant-based Vaccines Market Value (US$ Mn), by Against Infectious Agents, 2017–2031

Figure 19: Global Plant-based Vaccines Market Value (US$ Mn), by Anti-Cancer, 2017–2031

Figure 20: Global Plant-based Vaccines Market Value (US$ Mn), by Against Autoimmune Disorders, 2017–2031

Figure 21: Global Plant-based Vaccines Market Value Share Analysis, by Region, 2021 and 2031

Figure 22: Global Plant-based Vaccines Market Attractiveness Analysis, by Region, 2021–2031

Figure 23: North America Plant-based Vaccines Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 24: North America Plant-based Vaccines Market Value Share, by Country, 2020–2030

Figure 25: North America Plant-based Vaccines Market Attractiveness, by Country, 2020–2030

Figure 26: North America Plant-based Vaccines Market Value Share Analysis, by Type, 2021 and 2031

Figure 27: North America Pressure Relief Device Market Attractiveness Analysis, by Type, 2020–2030

Figure 28: North America Pressure Relief Device Market Attractiveness Analysis, by Type, 2020–2030

Figure 29: North America Plant-based Vaccines Market Value Share (%), by Plant source, 2021 and 2031

Figure 30: North America Plant-based Vaccines Market Attractiveness, by Plant source, 2021–2031

Figure 31: North America Plant-based Vaccines Market Value Share (%), by Application, 2021 and 2031

Figure 32: North America Plant-based Vaccines Market Attractiveness, by Application, 2021–2031

Figure 33: Europe Plant-based Vaccines Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 34: Europe Plant-based Vaccines Market Value Share, by Country/Sub-region, 2020–2030

Figure 35: Europe Plant-based Vaccines Market Attractiveness, by Country/Sub-region, 2020–2030

Figure 36: Europe Plant-based Vaccines Market Value Share Analysis, by Type, 2021 and 2031

Figure 37: Europe Plant-based Vaccines Market Attractiveness Analysis, by Type, 2020–2030

Figure 38: Europe Plant-based Vaccines Market Value Share (%), by Plant source, 2021 and 2031

Figure 39: Europe Plant-based Vaccines Market Attractiveness, by Plant source, 2021–2031

Figure 40: Europe Plant-based Vaccines Market Value Share (%), by Application, 2021 and 2031

Figure 41: Europe Plant-based Vaccines Market Attractiveness, by Application, 2021–2031

Figure 42: Asia Pacific Plant-based Vaccines Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 43: Asia Pacific Plant-based Vaccines Market Value Share, by Country/Sub-region, 2020–2030

Figure 44: Asia Pacific Plant-based Vaccines Market Attractiveness, by Country/Sub-region, 2020–2030

Figure 45: Asia Pacific Plant-based Vaccines Market Value Share Analysis, by Type, 2021 and 2031

Figure 46: Asia Pacific Plant-based Vaccines Market Attractiveness Analysis, by Type, 2020–2030

Figure 47: Asia Pacific Plant-based Vaccines Market Value Share (%), by Plant source, 2021 and 2031

Figure 48: Asia Pacific Plant-based Vaccines Market Attractiveness, by Plant source, 2021–2031

Figure 49: Asia Pacific Plant-based Vaccines Market Value Share (%), by Application, 2021 and 2031

Figure 50: Asia Pacific Plant-based Vaccines Market Attractiveness, by Application, 2021–2031

Figure 51: Latin America Plant-based Vaccines Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 52: Latin America Plant-based Vaccines Market Value Share, by Country/Sub-region, 2020–2030

Figure 53: Latin America Plant-based Vaccines Market Attractiveness, by Country/Sub-region, 2020–2030

Figure 54: Latin America Plant-based Vaccines Market Value Share Analysis, by Type, 2021 and 2031

Figure 55: Latin America Plant-based Vaccines Market Attractiveness Analysis, by Type, 2020–2030

Figure 56: Latin America Plant-based Vaccines Market Value Share (%), by Plant source, 2021 and 2031

Figure 57: Latin America Plant-based Vaccines Market Attractiveness, by Plant source, 2021–2031

Figure 58: Latin America Plant-based Vaccines Market Value Share (%), by Application, 2021 and 2031

Figure 59: Latin America Plant-based Vaccines Market Attractiveness, by Application, 2021–2031

Figure 60: Middle East & Africa Plant-based Vaccines Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 61: Middle East & Africa Plant-based Vaccines Market Value Share, by Country/Sub-region, 2020–2030

Figure 62: Middle East & Africa Plant-based Vaccines Market Attractiveness, by Country/Sub-region, 2020–2030

Figure 63: Middle East & Africa Plant-based Vaccines Market Value Share Analysis, by Type, 2021 and 2031

Figure 64: Middle East & Africa Plant-based Vaccines Market Attractiveness Analysis, by Type, 2020–2030

Figure 65: Middle East & Africa Plant-based Vaccines Market Value Share (%), by Plant source, 2021 and 2031

Figure 66: Middle East & Africa Plant-based Vaccines Market Attractiveness, by Plant source, 2021–2031

Figure 67: Middle East & Africa Plant-based Vaccines Market Value Share (%), by Application, 2021 and 2031

Figure 68: Middle East & Africa Plant-based Vaccines Market Attractiveness, by Application, 2021–2031

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

636

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved